These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23798620)

  • 21. The value of heparin concentration monitoring in off-pump coronary bypass surgery.
    Baykut D; Weichelt K; Wehrle J; Zerkowski HR; Bernet F
    Eur J Med Res; 2003 Apr; 8(4):161-4. PubMed ID: 12765862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identifying optimal heparin management during cardiopulmonary bypass in obese patients: A prospective observational comparative study.
    Haas E; Fischer F; Levy F; Degirmenci SE; Grunebaum L; Kindo M; Collange O; Mertes PM; Steib A
    Eur J Anaesthesiol; 2016 Jun; 33(6):408-16. PubMed ID: 26886138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anticoagulation of children undergoing cardiopulmonary bypass is overestimated by current monitoring techniques.
    Owings JT; Pollock ME; Gosselin RC; Ireland K; Jahr JS; Larkin EC
    Arch Surg; 2000 Sep; 135(9):1042-7. PubMed ID: 10982508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heparin dosing and monitoring for cardiopulmonary bypass. A comparison of techniques with measurement of subclinical plasma coagulation.
    Gravlee GP; Haddon WS; Rothberger HK; Mills SA; Rogers AT; Bean VE; Buss DH; Prough DS; Cordell AR
    J Thorac Cardiovasc Surg; 1990 Mar; 99(3):518-27. PubMed ID: 2308370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoagulation management in a patient with an acquired antithrombin III deficiency.
    Heller EL; Paul L
    J Extra Corpor Technol; 2001 Dec; 33(4):245-8. PubMed ID: 11806438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of high-dose thrombin time with activated clotting time for monitoring of anticoagulant effects of heparin in cardiac surgical patients.
    Wang JS; Lin CY; Karp RB
    Anesth Analg; 1994 Jul; 79(1):9-13. PubMed ID: 8010461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin monitoring during cardiac surgery. Part 2: Calculating the overestimation of heparin by the activated clotting time.
    Raymond PD; Ray MJ; Callen SN; Marsh NA
    Perfusion; 2003 Sep; 18(5):277-81. PubMed ID: 14604243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
    Kim H; Szlam F; Tanaka KA; van de Locht A; Ogawa S; Levy JH
    Anesth Analg; 2012 Aug; 115(2):244-52. PubMed ID: 22584552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High dose thrombin time versus the activated clotting time during cardiopulmonary bypass.
    de Jong MA
    J Extra Corpor Technol; 1999 Jun; 31(2):76-9. PubMed ID: 10724646
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternative methods for anticoagulation monitoring in pediatric patients with applicability to a patient with severe hemophilia A and circulating inhibitor.
    McNamara JL; Lombardi JP; Ferguson R; Manning PB; Gruppo RA
    J Extra Corpor Technol; 2001 Dec; 33(4):239-42. PubMed ID: 11806436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin sensitivity test for patients requiring cardiopulmonary bypass.
    DeBois WJ; Liu J; Elmer B; Ebrahimi H; Voevidko L; Lee LY; Krieger KH; Isom WW; Girardi LN
    J Extra Corpor Technol; 2006 Dec; 38(4):307-9. PubMed ID: 17312901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
    Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
    Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations.
    Despotis GJ; Summerfield AL; Joist JH; Goodnough LT; Santoro SA; Spitznagel E; Cox JL; Lappas DG
    J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1076-82. PubMed ID: 7983877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin concentrations in neonates during cardiopulmonary bypass.
    Davidson SJ; Tillyer ML; Keogh J; Hall J; Kelleher AA
    J Thromb Haemost; 2012 Apr; 10(4):730-2. PubMed ID: 22329742
    [No Abstract]   [Full Text] [Related]  

  • 35. Sensitivity of a modified ACT test to levels of bivalirudin used during cardiac surgery.
    Zucker ML; Koster A; Prats J; Laduca FM
    J Extra Corpor Technol; 2005 Dec; 37(4):364-8. PubMed ID: 16524153
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changing systems for measuring activated clotting times: impact on the clinical practice of heparin anticoagulation during cardiac surgery.
    Patteril M; Stafford-Smith M; Toffaletti JG; Bute BP; Milano CA; Welsby IJ
    Clin Chim Acta; 2005 Jun; 356(1-2):218-24. PubMed ID: 15936321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of activated clotting times measured using the Hemochron Jr. Signature and Medtronic ACT Plus during cardiopulmonary bypass with acute normovolemic haemodilution.
    Lee JM; Park EY; Kim KM; Won JC; Jung TK; Lee SK
    J Int Med Res; 2018 Feb; 46(2):873-882. PubMed ID: 28974132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. More effective suppression of hemostatic system activation in patients undergoing cardiac surgery by heparin dosing based on heparin blood concentrations rather than ACT.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Joiner-Maier D; Santoro SA; Spitznagel E; Weitz JI; Goodnough LT
    Thromb Haemost; 1996 Dec; 76(6):902-8. PubMed ID: 8972009
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring and management of anticoagulation in children requiring extracorporeal circulation.
    Malviya S
    Semin Thromb Hemost; 1997; 23(6):563-7. PubMed ID: 9469631
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.